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Mitochondria are the main oxygen consumers in cells and as such are the primary organelle affected by hypoxia. All hypoxia
pathology presumably derives from the initial mitochondrial dysfunction. An early event in hypoxic pathology in C. elegans is
disruption of mitochondrial proteostasis with induction of the mitochondrial unfolded protein response (UPRmt) and mitochondrial
protein aggregation. Here in C. elegans, we screen through RNAis and mutants that confer either strong resistance to hypoxic cell
death or strong induction of the UPRmt to determine the relationship between hypoxic cell death, UPRmt activation, and hypoxia-
induced mitochondrial protein aggregation (HIMPA). We find that resistance to hypoxic cell death invariantly mitigated HIMPA. We
also find that UPRmt activation invariantly mitigated HIMPA. However, UPRmt activation was neither necessary nor sufficient for
resistance to hypoxic death and vice versa. We conclude that UPRmt is not necessarily hypoxia protective against cell death but
does protect from mitochondrial protein aggregation, one of the early hypoxic pathologies in C. elegans.
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INTRODUCTION
Hypoxia, when extreme, will kill aerobic cells. The pathways
whereby cells go from healthy to dead when they encounter
hypoxia are many and complex. By the time cells are dying from
hypoxia, virtually every energy dependent process in the cell is
dysfunctional. Pathological processes that occur early in hypoxic
exposure when the pathology may still be reversible are of
particular interest. This pathologic time course certainly varies by
cell type and organism. In mammals, central nervous system
neurons and cardiac myocytes are exquisitely sensitive to hypoxia,
and during complete ischemia begin dying in only a few minutes
after dissolved oxygen is depleted [1, 2]. On the other hand,
peripheral neurons and skeletal myocytes can endure hours of a
similar reduction of oxygen and fully recover. Some organisms can
withstand prolonged severe hypoxia while others cannot. Certain
hibernating fish and reptiles modulate anabolic and catabolic
pathways and can tolerate near anoxic conditions over the winter
months, while living in normal oxygen levels in the summer [3].
The primary cellular determinants of this enormous range in
hypoxia tolerance are not well defined.
Mitochondria lie at the center of hypoxic biology and are
logically the first organelle affected when oxygen levels fall below
a crucial threshold. The vast majority of oxygen in metazoan cells
is consumed by mitochondrial cytochrome C oxidase enabling the
formation of ATP by ATP synthase. When oxygen levels fall,
cytochrome C oxidase function fails, ATP levels decrease, and
reactive oxygen species (ROS) are produced [4]. Besides ROS, the
ATP deficit generated by hypoxia creates havoc throughout the
cell including in the mitochondria where ATP-dependent pro-
cesses such as the proton gradient, protein transport, synthesis,
and folding are disrupted. The degree to which the failure of each
of these processes contributes to hypoxic cell death is unclear.
In the nematode C. elegans, we and others have identified
mutants and RNAis that protect worms from hypoxic cellular and
organismal injury [5–25]. Not surprisingly, what is clear from these
studies is that multiple pathways regulate hypoxic sensitivity.
However, to what degree the pathological state of the mitochon-
dria influences these pathways and vice versa has not been
systematically examined. We have previously shown that hypoxia
disrupts mitochondrial proteostasis [6, 26]. This disruption is
evident by hypoxic induction of the mitochondrial unfolded
protein response UPRmt [26], a conserved adaptive pathway that
responds to an increase in mitochondrial unfolded protein levels
by increasing the synthesis of mitochondrial chaperones, pro-
teases, and other proteins to restore proteostasis [27]. Hypoxia
also promotes aggregation of mitochondrial proteins [6, 26]. Both
UPRmt activation and hypoxia-induced mitochondrial protein
aggregation (HIMPA) occur well before there is evidence of cell
death in C. elegans or permanent behavioral deficits [6, 12]. Thus,
disruption of mitochondrial proteostasis occurs relatively early in
the hypoxic pathological cascade, but the consequence of
disruption of mitochondrial proteostasis and HIMPA on down-
stream cellular pathology, most importantly cell death is unclear.
Even the relationship of the UPRmt to HIMPA is not entirely clear.
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Activation of the UPRmt by three RNAis targeting mitochondrial
proteins reduced HIMPA and protected from hypoxic death [6].
However, loss of function of atfs-1, a gene which is thought to be
essential for UPRmt activation, also decreased HIMPA while atfs-1
gain-of-function mutants increased HIMPA [6]. Thus, whether the
UPRmt promotes HIMPA or inhibits it is unclear with the relatively
small number of UPRmt activators examined. Here, we make use of
the wide variety of C. elegans RNAis and mutants that have been
shown to be hypoxia protective, or to induce the UPRmt to address
three fundamental questions about the relationship between
mitochondrial proteostasis and hypoxic injury. Is activation of the
UPRmt a necessary component of hypoxia protective mechanisms?
Is UPRmt activation itself hypoxia protective? Does the UPRmt
promote or reduce HIMPA?
RESULTS
UPRmt activation not necessary for hypoxia resistance
We have previously performed a forward genome-wide screen in
Caenorhabditis elegans for genes, whose inactivation by RNAi
conferred a hypoxia resistance phenotype (HypR) and identified
about 200 such genes [9]. To explore the hypothesis that
activation of the UPRmt might be a common or even invariant
component of the mechanism underlying hypoxia resistance of
these RNAis, we screened through all the HypR RNAis that we
could recover from the library and confirm their identity by
sequence. Hundred and sixty-one of the HypR RNAi were
confirmed and tested for activation of the mitoUPR under
normoxic conditions as assessed by the fluorescence levels of
the mitoUPR transcriptional reporter hsp-6p::GFP (hsp-6 is the
ortholog of human mitochondrial chaperone HSP70 and is a
canonical component of the UPRmt) [28–31]. RNAi knockdown of
only five genes reproducibly induced the mitoUPR reporter (Fig.
1A). Thus, mitoUPR activation, at least as assessed by the hsp-6
reporter, is by no means necessary for hypoxia resistance.
The five RNAis that induced the mitoUPR were against pept-1, sucl-
2, C33F10.12, pdha-1, and R04F11.2 (Fig. 1A and Supplementary Table
S1). pept-1 encodes an oligopeptide transmembrane transporter,
localized to the apical plasma membrane in the intestine [32].
Reduction of function of pept-1 has been found to reduce protein
synthesis rates and levels of essential amino acids [5, 33]. A pept-1
loss of function mutant was recently isolated in a screen for hypoxia
resistant mutant worms, and its essential role in normal rates of
protein synthesis was confirmed [5]. How loss of function of pept-1
activates the UPRmt is unclear although recently the UPRmt has been
shown to regulate mitochondrial protein synthesis that would rely on
amino acids, whose transport depends on pept-1. On the other hand,
sucl-2, C33F10.12, pdha-1, R04F11.2 all encode mitochondrial proteins
that form or interact with multi-subunit proteins, where perturbations
in stoichiometry have been shown to induce the UPRmt [28, 30, 34].
Inactivation of these five genes by RNAi led to a range of UPRmt
reporter induction (Fig. 1B, C), from 2.3 to 13.7-fold that had no
correlation with the previously reported levels of hypoxia resistance
where pept-1(RNAi) was most resistant and sucl-2(RNAi) least resistant
to hypoxia [9]. atfs-1 is a transcription factor required for UPRmt
activation [35, 36]. The induction of hsp-6p::GFP by the five UPRmt-
activating HypR RNAis was fully suppressed by an atfs-1 loss-of-
function mutation (Fig. 1D, E), indicating that the induction of hsp-6p::
GFP by the five Hyp RNAis is acting through the canonical UPRmt
pathway.
Hypoxia induces mitochondrial protein aggregation (HIMPA)
[6, 26]. We found that inactivation of all five UPRmt-activating HypR
genes strongly lowered HIMPA as assessed by the ucr-11::GFP
mitochondrial protein aggregation reporter [6] (Fig. 1F, G). As shown
previously, atfs-1(lf) also reduced the aggregate levels; only pept-1
(RNAi) significantly reduced aggregates further in the atfs-1(lf)
background indicating that at least part of the effect of pept-1(RNAi)
is independent of atfs-1 (Fig. 1H). atfs-1(lf) did not suppress the
hypoxia resistance of any of the five RNAis; thus, neither atfs-1
function nor UPRmt activation is essential to their mechanisms of
hypoxia resistance (Fig. 1I). These results suggest that while
resistance to hypoxic cell death and HIMPA may be mechanistically
associated and that a functional UPRmt may be critical for aggregate
formation, the UPRmt is not required for protection from hypoxia and
in general activation of the UPRmt does not appear to commonly
accompany a hypoxia-resistant phenotype in C. elegans.
UPRmt activation reduces HIMPA
To examine more broadly the role of the UPRmt in HIMPA, we
tested 12 RNAis previously shown to activate the UPRmt
(Supplementary Table S2) [37]. We first confirmed that all 12
RNAis did indeed activate the UPRmt as measured by atfs-1-
dependent induction of the hsp-6::GFP transcriptional reporter
(Fig. 2A, C). All 12 UPRmt-activating RNAis strongly reduced HIMPA
(Fig. 2B). Unlike for the pept-1(RNAi), none of the 12 RNAis
significantly reduced HIMPA further in the atfs-1(lf) background
(Fig. 2D). Again, atfs-1(lf) paradoxically reduced HIMPA in the no
RNAi empty vector condition but not to the same degree of
reduction as the UPRmt RNAis. The mitochondrial translation
inhibitors doxycycline and meclocycline induce the UPRmt in an
atfs-1-dependent manner (Supplementary Fig. S1) [26, 38]. Like-
wise, doxycycline and meclocycline reduced HIMPA and did not
further reduce the aggregate levels in atfs-1(lf) animals (Fig. 2E).
Thus both genetic and pharmacological UPRmt activators reduce
HIMPA, while at the same time the UPRmt master regulator gene
atfs-1 paradoxically promotes HIMPA, as previously reported [6].
Activation of UPRmt does not necessarily confer hypoxia
resistance
We tested whether the 12 UPRmt-activating RNAis were protective
from hypoxic organismal death like the five UPRmt-activating HypR
RNAis and like doxycycline and meclocycline [9, 26, 38]. Five RNAis
(letm-1, pdhb-1, timm-17B1, tin-44, and tomm-22) produced
significant hypoxia resistance (Fig. 3A–E); five RNAis (cco-1, dnj-
21, mrpl-44, lpd-9, and wah-1) showed no significant effect on
hypoxic sensitivity (Fig. 3F–J); 2 RNAis (dlst-1, F15D3.6) produced
hypersensitivity to hypoxia (Fig. 3K, L). Interestingly, unlike for the
UPRmt-activating RNAis identified in our screen for strongly
hypoxia resistant RNAis (Fig. 1), the relatively weak hypoxia
resistance of these UPRmt-activating RNAis was atfs-1-dependent
(Fig. 3M–Q). Thus, our data shows that activation of the UPRmt may
in some genetic contexts confer atfs-1-dependent mild hypoxia
protection, but this is by no means a necessary consequence of
UPRmt activation.
TMRE stains mitochondrial aggregates
While examining the effect of hypoxia on mitochondrial
membrane potential, we discovered that the voltage sensitive
mitochondrial dye tetramethylrhodamine ethyl ester (TMRE) not
only stained functional mitochondria, but also stained hypoxia-
induced mitochondrial protein aggregates (Fig. 4A–C). This finding
in the wild type N2 strain importantly demonstrates that
aggregates occur in an animal with native mitochondrial proteins.
We then compared the aggregates visualized with TMRE to those
visible with the ucr-11::GFP reporter. The TMRE-stained aggregates
strongly colocalized with UCR-11::GFP aggregates (Fig. 4D–F).
Besides demonstrating importantly that the UCR-11::GFP aggre-
gates are not an artifact of an overexpressed and GFP-tagged
protein, TMRE staining can be used in all C. elegans strains to
detect mitochondrial aggregates and potentially in other models
of hypoxic injury.
HIMPA blocked by hypoxia resistance without UPRmt
activation
We have previously identified two distinct mechanisms, the
insulin/IGF-receptor pathway and the translation machinery, that
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regulate cytoplasmic proteostasis and profoundly modulate
hypoxic survival. The insulin/IGF-receptor pathway has been
shown to strongly regulate hypoxic sensitivity, aging, and
proteostasis in C. elegans [12, 23, 39, 40]. daf-2 encodes the C.
elegans insulin/IGF receptor, and daf-2 reduction-of-function
mutants are highly resistant to hypoxic injury via a mechanism
that requires the FOXO transcription factor DAF-16 [12, 23]. To test
whether the daf-2 pathway affected HIMPA, we built the daf-2
(e1370lf);gcIs46[ucr-11p::GFP] strain, confirmed that it was strongly
hypoxia resistant (Fig. 5A), and then scored for HIMPA. daf-2
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Fig. 1 Only a small subset of hypoxia resistant RNAis activate the UPRmt. A Fluorescence screen of RNAis for UPRmt activation. hsp-6p::GFP
induction was quantified for 161 Hyp RNAi clones with the functional categories as originally assigned [9]. Fold induction (mean) of GFP
fluorescence is relative to empty vector (EV) RNAi (L4440) (n= 10). Expression of GFP over 2-fold (blue dash line) of empty vector is considered
to be positive. Five positive hits confirmed in 2nd screen are shown in red. B Examples of hsp-6p::GFP expression induced by knockdown of
the five positive RNAi clones. zcIs13[hsp-6p::GFP] worms were placed onto RNAi bacteria from egg and imaged as young adults 3 days later.
Bar, 0.1 mm. C Quantification of GFP expression by corresponding RNAis as in B. Data (mean ± SD) were obtained from four independent
experiments, n= 30 animals; ***p < 0.001 with pooled data shown and p-values were calculated using unpaired t-test. D Examples of zcIs13
[hsp-6p::GFP] GFP expression induced by knockdown of positive five RNAi clones in atfs-1(tm4919) background. Worms were placed onto RNAi
bacteria from egg and imaged 3 days later. E Quantification of GFP expression by corresponding RNAis in atfs-1(tm4919) background. Data
(mean ± SD) were obtained from five independent experiments, n= 30 animals. F Examples of HIMPA in body wall muscles after hypoxia of
indicated RNAi treated gcIs46 worms. Green, UCR-11::GFP. Arrow, UCR-11::GFP aggregate. Bar, 2 μm. G Quantification of aggregate numbers as
in F. n= 15 animals from three independent experiments; ***p < 0.001. with pooled data shown. P-values were calculated using unpaired t-
test. H Quantification of HIMPA by UCR-11::GFP after hypoxia in body wall muscles of indicated RNAi treated atfs-1(tm4919); gcIs46 worms. n=
15 animals from three independent experiments; ***p < 0.001. with pooled data shown. P-values were calculated using unpaired t-test.
I Hypoxia resistance is maintained in atfs-1(lf ) background. Wild-type (N2) or atfs-1(tm4919) treated with indicated RNAis and hypoxic survival
was scored. n= 9 plates of worms (>100 worms/plate) from three independent trials. *p < 0.05, unpaired t-test.
Fig. 2 UPRmt activation Reduces HIMPA. A UPRmt-activating RNAis as assessed by hsp-6p::GFP expression. hsp-6p::GFP induction was
quantified for 12 RNAis previously shown to induce the UPRmt. Fold induction of GFP fluorescence is the mean fluorescence relative to empty
vector RNAi (L4440) (n= 10). Data were obtained from 10–36 individual animals for all panels; mean ± SD; **p < 0.01, ****p < 0.0001, unpaired
t-test. B UCR-11:GFP HIMPA reduced by the UPRmt activating RNAis. C UPRmt activation is partially or completely blocked in the atfs-1(tm4919
lf) animals. D atfs-1(lf) reduces aggregates and suppresses a further reduction in aggregates by UPRmt-activating RNAis. E Mitochondrial
translation inhibitors (doxycycline and meclocycline) reduce HIMPA in a non-additive manner along with atfs-1(lf ). **p < 0.01, ***p < 0.001,
****p < 0.0001, n or ns not significant versus EV @ Bonferroni-corrected p < 0.01, unpaired t-test.
J. Yan et al.
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Fig. 3 Activation of UPRmt does Not Necessarily Produce Hypoxia Resistance. The twelve UPRmt-activating RNAis are tested for hypoxic
sensitivity in the wild type background A–L and in the atfs-1(lf ) mutant background M–Q; significance @ p < 0.0001, F-test, simultaneous
nonlinear regression; data for each point is from 3 to 12 independent trials with at least 100 animals/trial, mean +/− sem. A–E Five RNAis
produced significant hypoxia resistance; F–J Five RNAis have no significant effect on hypoxic sensitivity; and K, L Two RNAis produced
significant hypersensitivity to hypoxia. M–Q The hypoxia resistance of the five RNAis is suppressed by atfs-1(lf ).
J. Yan et al.
5
Cell Death and Disease          (2021) 12:711 
(e1370) strongly reduced HIMPA as measured by UCR-11::GFP and
TMRE (Fig. 5B–E, G, H). HIMPA and hypoxic sensitivity were
restored in the daf-2(e1370);daf-16(mu86) double mutant strain
(Fig. 5A, F, H). daf-2 RNAi, which is strongly protective from
hypoxic injury [10], did not activate the UPRmt and therefore the
effect of daf-2(rf) on reducing aggregates is not explained by
UPRmt activation (Supplementary Fig. S2).
The translation machinery has been repeatedly implicated in C.
elegans hypoxic sensitivity [5, 8, 9, 11]. Translation machinery
mutations and RNAis that reduce protein synthesis are strongly
hypoxia protective [5, 11]. tars-1(gc52) and rars-1(gc47) carry
reduction of function mutations in threonyl-aminoacyl and
arginyl-aminoacyl tRNA synthetases, respectively, and are strongly
resistant to hypoxic death (Fig. 6A), as previously shown [5, 11].
Both translation machinery mutants fully blocked HIMPA as
measured by both UCR-11::GFP and TMRE (Fig. 6B–E, G, H). A
combination of loss-of-function mutations in two negative
regulators of the translation machinery, larp-1 and ncl-1 [5],
suppresses the hypoxia resistance of tars-1(gc52) (Fig. 6A) as
previously reported [5] and likewise restores HIMPA (Fig. 6F, H). As
was seen for daf-2, RNAi knockdown of rars-1 did not activate
UPRmt (Supplementary Fig. S2), demonstrating the effect on rars-1
reduction-of-function on hypoxic death and HIMPA was not due
to an activation of the UPRmt. These results indicate that hypoxia
protective mechanisms of daf-2/daf-16 signaling and reduction of
translation do not require UPRmt activation yet protect from
HIMPA.
DISCUSSION
Our study shows that a hypoxia resistant phenotype in C. elegans
is not commonly accompanied by UPRmt activation and that
UPRmt activation is not always hypoxia protective. In other words,
UPRmt activation is neither necessary nor sufficient for protection
from hypoxic cell death in C. elegans. However, among RNAis
selected solely for their ability to induce the UPRmt we did find a
strong enrichment for hypoxia resistance, where five of the twelve
UPRmt-activating RNAis conferred hypoxia resistance. By compar-
ison, in a screen of over 16,000 RNAis, only 199 were found to
reproducibly produce hypoxia resistance [9]. While these twelve
are a small sample and the whole genome RNAi screen
deliberately ignored weak hypoxia resistance phenotypes, this
approximately 30-fold enrichment for hypoxia resistance suggests
that UPRmt activation may provide hypoxia protection in certain
genetic backgrounds.
We also examined the effect of hypoxia resistance and UPRmt
activation on HIMPA. We found that resistance to hypoxic death
and resistance to HIMPA were invariantly associated. All RNAis or
mutants that were resistant to hypoxic death reduced HIMPA.
Importantly, the strongly hypoxia resistant daf-2, tars-1, and rars-1
mutants or RNAis block HIMPA without activating the UPRmt. Thus,
UPRmt activation is neither necessary for resistance to hypoxia nor
for abrogation of HIMPA. We also found that all UPRmt-activating
RNAis as well as doxycycline and meclocycline, which strongly
activate the UPRmt, brought hypoxia-induced mitochondrial
aggregates to near background levels. To be clear, both
hypoxia-resistant and non-hypoxia resistant UPRmt-activating
RNAis strongly reduced HIMPA. The effect of the RNAis on
activation of the UPRmt was mostly if not completely dependent
on a functional atfs-1 gene. This was to be expected as hsp-6
activation is dependent on ATFS-1 [34, 36].
The reduction in the aggregates by both UPRmt activation and
atfs-1 loss-of-function is a puzzling paradox, albeit consistent with
our previously published results [6]. We previously showed that
atfs-1 RNAi and the atfs-1(tm4919) loss-of-function mutant
reduced HIMPA and an atfs-1 gain-of-function mutant increased
aggregates [6]. We had also previously shown that cco-1, letm-1,
and F02A9.4 RNAis reduced HIMPA, but we attributed this effect to
their hypoxia resistance or reduction in the levels of their
corresponding proteins that might form the aggregates them-
selves [6]. We found here that of these three only letm-1 RNAi
reproducibly conferred hypoxia resistance yet all three RNAis,
indeed all of the UPRmt activating RNAis, strongly reduced HIMPA.
Thus, clearly hypoxia resistance is not necessary for this effect. To
Fig. 4 TMRE Stains HIMPA. (Scale bar). A Wild type worms exposed to 12 h of hypoxia, stained with TMRE and mounted immediately. TMRE
stains the mitochondria and HIMPA. B Normoxic wild type worms (not exposed to hypoxia) stained with TMRE and mounted immediately. Few
TMRE-stained aggregates in normoxic wild type animals. C Quantitation of aggregates in wild type worms. Mean ± SD of ten animals ****p <
0.0001, unpaired t-test. D HIMPA visible by GFP in gcIs46[UCR-11::GFP]. E HIMPA visible with TMRE staining in gcIs46. F Merge of D and E. 79.7%
of UCR-11::GFP aggregates colocalized with TMRE aggregates in muscle (n= 1472). 93.5% of TMRE aggregates in muscle colocalized with UCR-
11::GFP aggregates (n= 1255). Number of images = 50. Scale bars = 2 µm.
J. Yan et al.
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reconcile that both atfs-1(lf) and atfs-1-dependent UPRmt activa-
tion reduce aggregates, we hypothesize that ATFS-1 functions
both to inhibit HIMPA by activating the UPRmt and to promote
HIMPA through some other unknown mechanism (Fig. 7). ATFS-1
could both function to reduce aggregates by activation of its
downstream UPRmt targets, and in the absence of UPRmt
activation function to promote HIMPA through an unknown
mechanism. The fact that the level of activation of the hsp-6::GFP
transcriptional reporter does not correlate with the ability to
suppress hypoxia-induced aggregates (Fig. 2A, B) suggests that
the HSP-6 chaperone levels are not directly responsible for the
effect of the UPRmt on aggregation, or that a very low threshold of
hsp-6 induction suppresses aggregation fully. Which atfs-1-
regulated protein(s) might be responsible for promoting HIMPA
is unknown; ATFS-1 has been shown to control the synthesis of a
large number of proteins involved in mitochondrial proteostasis
and mitochondrial function as well as some non-mitochondrial
proteins [34, 41, 42]. Likewise, cytoplasmic and ER proteostasis
pathways regulate the UPRmt and mitochondrial proteostasis [42].
Thus, ATFS-1 may function in concert with one of those non-UPRmt
pathways to regulate HIMPA directly.
An important technical advance of this work is the discovery
that TMRE stains HIMPA. TMRE is a lipophilic cationic dye that
accumulates in the matrix of viable mitochondrial, where the
membrane potential is highly negative relative to the intermem-
brane space [43, 44]. Besides membrane potential driven
accumulation, TMRE has been shown to bind to both surfaces of
the inner membrane; however, whether it is binding to lipids,
proteins, or both at the inner mitochondrial membrane is unclear
[43]. The aggregates appear to be in the matrix of the
mitochondria although the resolution is inadequate to be certain.
Other than UCR-11::GFP which strongly colocalizes with the TMRE-
stained aggregates, we have no empirical evidence for what
composes the TMRE-aggregates. In principle, TMRE can bind non-
specifically to hydrophobic and negatively charged surfaces. Thus,
denatured mitochondrial proteins, lipids, and even nucleic acids
are reasonable candidates. Regardless of the nature of the binding
target, the discovery that TMRE binds to hypoxia-induced
mitochondrial aggregates rules out that HIMPA is an artifact of
the GFP reporter overexpression. TMRE can be used to examine
for HIMPA in any hypoxic/ischemic model without the need for
expression of a tagged protein, electron microscopy, or
immunofluorescence.
In summary, resistance to hypoxic organismal death and
resistance to hypoxia-induced mitochondrial protein aggregation
are strongly correlated. This suggests that HIMPA may be an early
hypoxic pathology along the pathway to eventual hypoxic cell
death. However, it is important to emphasize that we have not
directly measured any aspect of mitochondrial function to
determine whether HIMPA correlates with abnormalities in
mitochondrial function. On the other hand, activation of the
UPRmt is neither necessary nor sufficient for hypoxia resistance but
may weakly promote hypoxic survival in certain contexts.
Activation of the UPRmt did invariably reduce HIMPA whether or
not it conferred resistance to hypoxic death. This effect of the
UPRmt favors a model, where the UPRmt directly abrogates
Fig. 5 Reduction-of daf-2 function Reduces HIMPA. A As previously reported [12], daf-2(e1370) animals are hypoxia resistant in a daf-16
dependent manner and in the gcIs46 background (mean ± SD, n= 4–12 independent trials). B, C Comparison of gcIs46::GFP HIMPA in the wild
type B and daf-2(e1370) background C. D–F Comparison of HIMPA by TMRE in wild type (N2), daf-2(e1370), and in daf-2(e1370);daf-16(mu86).
G Quantitation of GFP HIMPA in gcIs46 and daf-2(e1370);gcIs46 (mean ± SD of 18 animals). H Quantitation of TMRE HIMPA in the strains with the
noted genotypes (mean ± SD of 11–24 animals). ****p < 0.0001, unpaired t-test. Scale bars = 2 µm.
J. Yan et al.
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mitochondrial protein aggregation during hypoxia. Future inves-
tigation will continue to define the breadth of mechanisms that
protect cells from hypoxic death, to define the components of the
UPRmt that inhibit HIMPA, and the ATFS-1-regulated mechanism
that promotes it.
MATERIALS AND METHODS
C. elegans strains and culture methods
C. elegans strains were cultured and maintained at 20 °C on NGM agar with
OP50 E. coli food unless otherwise noted [45]. The N2 (Bristol) strain was
the standard wild-type strain from the Caenorhabditis Genetics Center
(CGC, University of Minnesota). The mitochondrial UPR transcriptional
reporter strain SJ4100 (zcIs13[hsp-6p::GFP]) was obtained from the CGC.
gcIs46 [ucr-11::GFP] and atfs-1(tm4919);gcIs46 were generated as previously
described [6]. atfs-1(tm4919);zcIs13, daf-2(e1370);gcIs46, rars-1(gc47);gcIs46,
and tars-1(gc53);gcIs46 were generated in this study by routine genetic
crosses and confirmation by phenotypes and/or PCR genotyping.
Hypoxic incubations and hypoxic death
Synchronized young adult worms were subjected to hypoxia as described
previously except that hypoxic incubation temperature was 26–26.5 °C
[12, 46]. Briefly, each plate of worms was washed into a 1.5ml tube with 1ml
of M9 buffer (22mM KH2PO4, 22mM Na2HPO4, 85mM NaCl, and 1mM
MgSO4), and after the worms settled by gravity, all but 100 μl of M9 was
removed. The tubes were then placed in the anaerobic chamber (Forma
Scientific, Waltham, MA, USA) for incubation times ranging from 10 to 34 h as
indicated. Oxygen tension was always ≤ 0.3%. Following the hypoxic
incubation unless otherwise noted, worms were transferred using glass
Pasteur pipettes onto seeded NGM plates and recovered at 20 °C for 24 h.
Normoxic incubations were otherwise identical except performed in a 26.5 °C
room air incubator. Organismal death was scored as previously described
[46]. Briefly, animals were scored as dead if pharyngeal pumping,
spontaneous and evoked movement (touching with a platinum wire) were
Fig. 6 Loss-of function mutations in the translation machinery reduces HIMPA. A As previously reported [5, 11], rars-1 (gc47) and tars-1
(gc52) animals are resistant to hypoxia and the resistance of tars-1(gc52) is maintained in a gcIs46 background and is suppressed by larp-1(q783)
ncl-1(gc53) (mean ± SD of 6–12 independent trial with >100 animals/trial). B, C Comparison of gcIs46::GFP HIMPA in the wild type (B) and tars-1
(gc52) backgrounds (C). D–F Comparison of HIMPA by TMRE in wild type (N2), tars-1(gc52), and in tars-1(gc52); larp-1(q783)ncl-1(gc53) animals G
Quantification of GFP aggregates in gcIs46 and tars-1(gc52);gcIs46 (mean ± SD of 12–19 animals). H Quantification of TMRE aggregates in the
strains with the noted genotypes (mean ± SD of 10–28 animals).****p < 0.0001, unpaired t-test. Scale bars = 2 µm.
Fig. 7 Hypoxia induces organellar stress that can manifest in the
mitochondria as protein aggregation (HIMPA). ATFS-1, the UPRmt
master regulator, both reduces HIMPA by activating the UPRmt and
promotes HIMPA by an unknown mechanism. HIMPA may con-
tribute to but is not required for cellular and organellar death.
J. Yan et al.
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not observed. For the mitochondrial aggregates assay, synchronized worms
were kept on NGM plates and placed into anaerobic chamber for 12 h and
then mounted for confocal imaging on glass slides [6].
RNAi experiments
The bacterial RNAi feeding strain L4440 carrying the empty RNAi vector
strain was from the Ahringer C. elegans RNAi library (MRC Gene service,
Swindon, UK) and was used as the negative control (Empty Vector-EV) for
all RNAi experiments [47]. Bacterial strains containing RNAi plasmids were
cultured and induced with 0.1% β-lactose in 100mg/ml ampicillin for 24 h
at 23 °C as described previously [9]. Worms were synchronized on RNAi
plates for 3.5 days (N2) or 4.5 days (rars-1(gc47) background) until reaching
adulthood; worms not reaching adulthood were excluded.
Mitochondrial UPR reporter and screening
SJ4100 (zcIs13[hsp-6p::GFP]) was used as a reporter for mitochondrial UPR
activation [28]. Animals were synchronized from eggs by bleaching gravid
adults, allowed to develop to adulthood, and then mounted on agar pads
for imaging. All UPRmt fluorescent reporter determinations were performed
with worms exposed only to normoxic conditions. Briefly, a minimum of
ten worms were mounted onto an agar pad on a standard microscope
slide and imaged on a Zeiss axioskope 2 at ×10 magnification. Using
ImageJ software (https://imagej.nih.gov/ij/), each worm was outlined and
the fluorescence intensity within the area was measured and background
intensity was then subtracted to obtain the total intensity/worm as
previously described [26].
Chemical treatment and TMRE staining. Concentrated stocks of doxycy-
cline (225mM) and meclocycline (294mM) in DMSO (Dimethyl sulfoxide)
(Sigma-Aldrich Corp, St. Louis, MO, USA), were diluted to a final
concentration of 100 μM with nuclease-free, deionized water and 300 µl
was spread evenly onto a NGM plate seeded with OP50 onto which were
placed synchronized eggs allowed to develop into 1-day-old adults. Plates
containing TMRE (ThermoFisher, Waltham, MA, USA) were made the same
way as described above with 300 µl at a final concentration of 5 μM spread
onto the plate. For TMRE staining, 1-day-old synchronized worms were
transferred onto the TMRE-containing plates for 2 h before the plates were
placed into the anaerobic chamber for 12 h for hypoxic exposure.
Aggregate imaging and counting
Images of UCR-11::GFP and TMRE staining were acquired with confocal
microscopy as previously described [6, 26]. Briefly, paralysis was produced
by mounting worms in a solution of 50mM levamisole (Sigma-Aldrich
Corp., St. Louis, MO, USA) in M9 prior to imaging. Images were acquired
from at least 5–10 randomly selected worms at 1024 × 1024 resolution
using a 63× objective with 8 × zoom producing a 23.07 × 23.07 μm image
(defined as one high power field, HPF). All images were acquired as a ten
slice Z-stack with scan speed of 800–1800 Hz and flattened as a maximum
intensity projection prior to analysis. The wavelength of the laser to
capture the signal for GFP and TMRE signals was 500–530 nm and
620–700 nm, respectively. Aggregates were counted per HPF by an
observer blinded to condition.
Statistics
Two-sided unpaired or paired, as appropriate, t-tests were used for
statistical comparisons and all variances were of a similar magnitude
except for death versus hypoxic exposure time curves (Fig. 3), where
simultaneous curve-fitting was performed [48, 49]. Simultaneous curve-
fitting forced the test RNAi death curve fit and the L4440 empty vector
control curve fit to the same hypoxic exposure time producing 50% death
(LT50) and F-tests were performed for statistical significance of the change
in variance of the LT50 versus fitting each curve independently. Statistics
were calculated using GraphPad Prism 6.01 (San Diego, CA, USA) for
simultaneous curve-fitting, t-tests, or Excel 2007 for t-tests (Microsoft,
Redmond, WA). Values are expressed as mean ± SD of at least three
independent experiments. A minimum p value of ≤0.05 was considered
significant and was Bonferroni-corrected for multiple comparisons where
appropriate. Sample sizes for technical replicates for number of animals
was based on the variability from animal to animal for fluorescence-based
assays and was always ≥10 or a minimum of 30 animals, where a percent
of the population was scored. Based on our previous experience with
hypoxic death population assays biological replicates were at least three
per condition, and if significant variability was observed among replicates
more were performed until clear reproducibility was achieved. In terms of
randomization, strains were not randomized as they are genetically
identical and raised under environmentally identical conditions.
DATA AVAILABILITY
The raw data from the screen of the RNAi strain set are available upon request. All
other data generated and analyzed during this study are included in the published
article. The unique C. elegans strains generated for this study are available upon
request.
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